12.2023

Ventac Partners portfolio company Orbit Genomics (www.orbitgenomics.com) is named A Deep Tech Pioneer by Hello Tomorrow. Out of an astonishing 4,500 applications from 120 countries, Orbit Genomics stood out as one of the most promising in the realm of deep tech. This prestigious recognition signifies a significant milestone in Orbit Genomics journey to transforming complex disease diagnosis, treatment, and prevention through early warning genomics. Orbit Genomics first target is early detection of lung cancer. For further information click here.